Trump Can Reduce Drug Prices By Promoting Competition

A new study by the Schaeffer Center for Health Policy at USC highlights the need for decisive action by the president, Congress, and federal anti-trust regulators to curb abuses by medical market middlemen that are driving up prices, causing drug shortages, and harming patients.